Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Type 1 Diabetes Preclinical Testing Program Resource Report Resource Website |
Type 1 Diabetes Preclinical Testing Program (RRID:SCR_006861) | T1D-PTP, NIDDKT1D-PTP | resource, service resource | THIS RESOURCE IS NO LONGER IN SERVICE, documented August 22, 2016. Investigator access is provided to the established facilities and expertise needed to extend, enhance and validate preclinical studies of promising new therapeutics in cases where additional preclinical testing is needed to validate potential therapies under disease-specific conditions and in multiple animal models before therapeutics can enter the Type 1 Diabetes Rapid Access to Intervention Development (T1D-RAID) development pipeline. The T1D-RAID program provides resources for pre-clinical development of drugs, natural products, and biologics that will be tested as new therapeutics in type 1 diabetes clinical trials. The T1D-RAID program is not currently accepting applications. The T1D-PTP program currently supports two contracts, which are separate from each other and from the T1D-RAID NCI contract resources, to assist in preclinical development of therapeutics for T1D: * Agents to be tested for Preclinical Efficacy in Prevention or Reversal of Type 1 Diabetes in Rodent Models. Type 1 Diabetes Preclinical Testing Program (T1D-PTP) (NOT-DK-09-006) * Needs for Preclinical Efficacy Testing of Promising Agents to Prevent or Reverse Diabetic Complications (NOT-DK-09-009) The T1D-RAID and T1D-PTP are programs intended to remove the most common barriers to progress in identification and development of new therapies for Type 1 Diabetes. The common goal of these programs is to support and provide for the preclinical work necessary to obtain proof of principle establishing that a new molecule or novel approach will be a viable candidate for expanded clinical evaluation. | testing, therapeutic, clinical, drug, preclinical, therapy, drug development, high-throughput screening, animal model, formulation, pharmacology, toxicology |
is related to: Type 1 Diabetes - Rapid Access to Intervention Development is related to: NIDDK Information Network (dkNET) has parent organization: NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases |
Type 1 diabetes, Diabetes | NIDDK | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_152741 | SCR_006861 | Type 1 Diabetes Preclinical Testing Program (T1D-PtP), NIDDKType 1 Diabetes Preclinical Testing Program | 2026-09-12 01:03:16 | 0 | |||||
|
English Longitudinal Study of Ageing Resource Report Resource Website 10+ mentions |
English Longitudinal Study of Ageing (RRID:SCR_006727) | ELSA | data or information resource, data set | An interdisciplinary data resource on health, economic position and quality of life as people age. Longitudinal multidisciplinary data from a representative sample of the English population aged 50 and older have been collected. Both objective and subjective data are collected relating to health and disability, biological markers of disease, economic circumstance, social participation, networks and well-being. Participants are surveyed every two years to see how people''s health, economic and social circumstances may change over time. One of the study''s aims is to determine the relationships between functioning and health, social networks, resources and economic position as people plan for, move into and progress beyond retirement. It is patterned after the Health and Retirement Study, a similar study based in the United States. ELSA''s method of data collection includes face-to-face interview with respondents aged 50+; self-completion; and clinical, physical, and performance measurements (e.g., timed walk). Wave 2 added questions about quality of health care, literacy, and household consumption, and a visit by a nurse to obtain anthropometric, blood pressure, and lung function measurements, as well as saliva and blood samples, and to record results from tests of balance and muscle strength. Another new aspect of Wave 2 is the ''Exit Interview'' carried out with proxy informants to collect data about respondents who have died since Wave 1. This interview includes questions about the respondents'' physical and psychological health, the care and support they received, their memory and mood in the last year of their life, and details of what has happened to their finances after their death. Wave 3 data added questions related to mortgages and pensions. The intention is to conduct interviews every 2 years, and to have a nurse visit every 4 years. It also is envisioned that the ELSA data will ultimately be linked to available administrative data, such as death registry data, a cancer register, NHS hospital episodes data, National Insurance contributions, benefits, and tax credit records. The survey data are designed to be used for the investigation of a broad set of topics relevant to understanding the aging process. These include: * health trajectories, disability and healthy life expectancy; * the determinants of economic position in older age; * the links between economic position, physical health, cognition and mental health; * the nature and timing of retirement and post-retirement labour market activity; * household and family structure, social networks and social supports; * patterns, determinants and consequences of social, civic and cultural participation; * predictors of well-being. Current funding for ELSA will extend the panel to 12 years of study, giving significant potential for longitudinal analyses to examine causal processes. * Dates of Study: 2002-2007 * Study Features: Longitudinal, International, Anthropometric Measures * Sample Size: ** 2000-2003 (Wave 1): 12,100 ** 2004-2005 (Wave 2): 9,433 ** 2006-2007 (Wave 3): 9,771 ** 2008-2009 (Wave 4): underway Links * Economic and Social Data Service (ESDS): http://www.esds.ac.uk/longitudinal/about/overview.asp * ICPSR: http://www.icpsr.umich.edu/icpsrweb/ICPSR/studies/00139#scope-of-study | middle adult human, late adult human, adult human, biological marker, direct assessment, physical impairment, interview, clinical, physical, performance, health care, literacy, household consumption, anthropometric, blood pressure, lung function, measurement, saliva, blood, balance, muscle strength, psychological health, care, support, memory, mood, longitudinal, international, health, disability, economic circumstance, social participation, well-being, behavior, family life, health care, health status, household income, income, marriage, retirement, social network |
is listed by: Inter-university Consortium for Political and Social Research (ICPSR) has parent organization: University College London; London; United Kingdom |
Aging | NIA ; UK Department of Health ; UK Department of Social Security ; other UK government departments |
Public for the first 3 waves through the University of Essex Economic and Social Data Service (ESDS) website. Greater restrictions may apply for researchers seeking to access more sensitive data (e.g., Geographical classificatory variables and DNA). | nlx_151823 | SCR_006727 | English Longitudinal Study of Ageing (ELSA), ELSA - English Longitudinal Study of Ageing, English Longitudinal Study of Aging | 2026-09-12 01:03:16 | 16 | |||||
|
Efficacy and Mechanisms of Glutamine Dipeptide in the Surgical Intensive Care Unit Resource Report Resource Website |
Efficacy and Mechanisms of Glutamine Dipeptide in the Surgical Intensive Care Unit (RRID:SCR_006806) | GLND | clinical trial, resource | Multi-center, double-blind, placebo-controlled, intent-to-treat Phase III trial, designed to determine the effect of parenteral glutamine (GLN) dipeptide on important clinical outcomes in patients requiring surgical intensive care unit (SICU) care and parenteral nutrition (PN) after cardiac, vascular, or intestinal surgery. Patients who required PN and SICU care will receive either standard glutamine (GLN)-free PN (STD-PN) or isocaloric, isonitrogenous alanyl-glutamine dipeptide (AG)-PN until enteral feedings are established. The study will determine whether AG-PN decreases hospital mortality, nosocomial infection and other important indices of morbidity and will obtain mechanistically relevant observational data in the subjects on whether AG-PN a) increases serial blood concentrations of glutathione (GSH), heat shock proteins (HSP)-70 and -27, and glutamine; b) decreases the serum presence of the bacterial products flagellin and lipopolysaccharide (LPS) and the adaptive immune response to these mediators; and c) improves key indices of innate and adaptive immunity. | parenteral nutrition, glutamine, glutamine dipeptide, clinical, outcome, adult human, mortality, nosocomial infection, immune cell function, hospital morbidity, morbidity, intensive care |
is listed by: ClinicalTrials.gov is listed by: NIDDK Information Network (dkNET) is listed by: NIDDK Research Resources has parent organization: Emory University; Georgia; USA |
Critical illness | NIDDK U01DK069322 | PMID:18596310 | nlx_152823 | http://www.sph.emory.edu/GLND | SCR_006806 | Phase III Study on the Efficacy of Glutamine Dipeptide-Supplemented Parenteral Nutrition in Surgical ICU Patients, Efficacy and Mechanisms of GLN Dipeptide in the SICU, Efficacy and Mechanisms of GLN Dipeptide in the SICU (GLND), GLND trial | 2026-09-12 01:03:16 | 0 | ||||
|
PathXL TMA Resource Report Resource Website |
PathXL TMA (RRID:SCR_005596) | PathXL TMA | commercial organization, software resource | Tissue microarray (TMA) Software used for Biomarker Discovery that allows TMA experiments to be performed anytime, anywhere, reducing administrative costs and time. It is designed to support TMA scoring workflow and allows configuration of experiments in minutes. Access and view clinical metadata, the TMA core, scoring criteria and the TMA map all on a single interface. | tissue microarray, pathology, clinical | is listed by: OMICtools | OMICS_00817 | SCR_005596 | 2026-09-12 01:03:15 | 0 | |||||||||
|
Matlab Health and Socio-Economic Survey Resource Report Resource Website |
Matlab Health and Socio-Economic Survey (RRID:SCR_008942) | MHSS | data or information resource, data set | A data set of the health and socioeconomic factors that affect the elderly in Matlab, a region of rural Bangladesh. The survey captures measurements and statistics such as adult survival, health status, health care utilization, resource flows between generations and the impact of community services and infrastructure on adult health care. Data was collected through surveys that touch on four topics: household and individual information; determinants of natural fertility; migration out of the community; and community and provider survey of healthcare and education infrastructure. | survey, bangladesh, adult, birth control, child development, culture, fertility, health behavior, health care, health care facility, health care service, health services utilization, health status, household budget, household expenditure, housing condition, infant feeding, reproductive history, school, social network, socioeconomic status, traditional medicine, women's health care, socioeconomic, behavior, family, community, household, woman, female, pregnancy status, outmigrant, family planning, international, questionnaire, clinical, interview, research, data |
is listed by: Inter-university Consortium for Political and Social Research (ICPSR) has parent organization: National Archive of Computerized Data on Aging (NACDA) |
Aging | NIA P01AG11952 | Public, Data and documentation may be used for academic and public policy research purposes only | nlx_151854 | SCR_008942 | Matlab Health and Socioeconomic Survey, Matlab Health and Socioeconomic Survey (MHSS), Matlab Health and Socio-Economic Survey (MHSS) | 2026-09-12 01:03:18 | 0 | |||||
|
ACCORD Resource Report Resource Website 100+ mentions |
ACCORD (RRID:SCR_009015) | ACCORD | clinical trial, resource | Study testing whether strict glucose control lowers the risk of heart disease and stroke in adults with type 2 diabetes. In addition the study is exploring: 1) Whether in the context of good glycemic control the use of different lowering lipid drugs will further improve these outcomes and 2) If strict control of blood pressure will also have additional beneficial effects on reducing cardiovascular disease. The design was a randomized, multicenter, double 2 X 2 factorial trial in 10,251 patients with type 2 diabetes mellitus. It was designed to test the effects on major CVD events of intensive glycemia control, of fibrate treatment to increase HDL-cholesterol and lower triglycerides (in the context of good LDL-C and glycemia control), and of intensive blood pressure control (in the context of good glycemia control), each compared to an appropriate control. All 10,251 participants were in an overarching glycemia trial. In addition, one 2 X 2 trial addressed the lipid question in 5,518 of the participants and the other 2 X 2 trial addressed the blood pressure question in 4,733 of the participants. The glycemia trial was terminated early due to higher mortality in the intensive compared with the standard glycemia treatment strategies. The results were published in June 2008 (N Eng J Med 2008;358:2545-59). Study-delivered treatment for all ACCORD participants was stopped on June 30, 2009, and the participants were assisted as needed in transferring their care to a personal physician. The lipid and blood pressure results (as well as the microvascular outcomes and eye substudy results) were published in 2010. All participants are continuing to be followed in a non-treatment observational study. | middle adult human, late adult human, glycemic control, lowering lipid drug, blood pressure, lipid, clinical |
is related to: NIDDK Information Network (dkNET) has parent organization: National Heart Lung and Blood Institute |
Cardiovascular disease, Stroke, Type 2 diabetes, Diabetes, Aging | NHLBI ; NIDDK ; NEI ; CDC ; NIA |
PMID:23490598 PMID:23253271 PMID:23238658 PMID:22723583 PMID:22646230 |
nlx_152746 | SCR_009015 | Action to Control Cardiovascular Disease Risk in Diabetes | 2026-09-12 01:03:18 | 180 | |||||
|
OAI Knowledge base Resource Report Resource Website 50+ mentions |
OAI Knowledge base (RRID:SCR_028107) | data or information resource, knowledge base | Centralized, annotated repository for the Osteoarthritis Initiative (OAI) study, designed to accelerate research by organizing and linking extensive clinical, imaging (MRI/X-ray), and biomarker data. It aims to help researchers analyze knee osteoarthritis prevention, treatment, and progression. | DRKB, clinical, imaging, MRI, X-ray, biomarker, data, osteoarthritis | Free, Freely available, | SCR_028107 | Osteoarthritis Initiative Knowledge base | 2026-09-12 01:05:43 | 50 | ||||||||||
|
Vanderbilt University Medical Center Pharmacology Resource Report Resource Website |
Vanderbilt University Medical Center Pharmacology (RRID:SCR_001450) | Vanderbilt Pharmacology | data or information resource, department portal, organization portal, portal | At the Department of Pharmacology at Vanderbilt University Medical Center we engage in scientific discovery to elucidate biological mechanisms and develop novel therapeutics. We provide training focused on critical thinking to promote innovation, scholarship and integrity. To this end, we foster creativity, collegiality, and leadership. The Department is one of the most distinguished Pharmacology departments in the country and have placed in the top two NIH ranking positions for sixteen of the last twenty years. Research interests in the Department include five major areas: signal transduction, neuroscience, bioactive lipid metabolism, genetic basis of cardiovascular dysfunction, and drug metabolism. Molecules under investigation include G-protein coupled receptors (rhodopsin, adrenergic, serotonin and receptors), heterotrimeric G-proteins, ion channels, transporters and regulatory proteins such as arrestins, protein kinases and protein phosphatases. A strength in our research and training environment is that Vanderbilt University has a world-acclaimed Division of Clinical Pharmacology, which links the Department of Medicine with the Department of Pharmacology. Faculty members in the Division of Clinical Pharmacology focus on human disease and clinical enigmas as the origin of their questions for research. Basic scientists who pursue their inquiries in this environment are continually informed by their colleagues of the pathophysiological and potential therapeutic relevance that can be achieved by appropriate focus of their efforts. We have created one of the first programs in the country to answer the call from the National Institutes of Health (NIH) for more scientists trained in the area of drug discovery and development. A unique feature of the department is our outstanding Ph.D. training program. Almost 60 scientists in training are addressing important issues in fields such neuroscience, cardiovascular development, receptor signaling, and drug metabolism. Scientists in these areas are linked by a common interest in, and understanding of, the basic principles of drug action and design. This perspective makes our trainees ideally suited for a wide range of careers and our program is committed to developing leaders in academia, industry, and regulatory affairs. Postdoctoral and other positions are available. | pharmacology, clinical, signal transduction, neuroscience, bioactive lipid metabolism, cardiovascular dysfunction, drug metabolism, g-protein coupled receptor, rhodopsin, adrenergic, serotonin, receptor, heterotrimeric g-protein, ion channel, transporter, regulatory protein, arrestins, protein kinase, protein phosphatase, disease, drug discovery, drug development |
has parent organization: Vanderbilt University School of Medicine; Tennessee; USA has parent organization: Vanderbilt University Medical Center; Tennessee; USA |
Free, Freely Available | nif-0000-02295 | http://www.mc.vanderbilt.edu/vumcdept/pharm/ | SCR_001450 | Vanderbilt Department of Pharmacology | 2026-09-12 12:55:25 | 0 | ||||||
|
PD-DOC Resource Report Resource Website |
PD-DOC (RRID:SCR_001596) | PD-DOC | data or information resource, data repository, database, portal, service resource, storage service resource, topical portal | THIS RESOURCE IS NO LONGER IN SERVICE, documented on December 02, 2011. Notice: This domain name expired on 10/29/11 and is pending renewal or deletion PD-DOC is a portal and a database resource, hosting a database and linking to other databases and data sets of clinical and translational data. PD-DOC functions to organize and facilitate clinical and translational research in Parkinson's disease. The PD-DOC Database contains standardized data collected by user institutions on large numbers of patients with Parkinsons disease and other parkinsonian disorders. In some cases, data is obtained at a single point in time, while in others data is collected repeatedly over time. The PD-DOC Database is composed of the Core Data Set (CDS) which consists of those variables required to be gathered for each subject whose data is entered into the PD-DOC database. In 2005, working groups of Udall Center and invited experts deliberated to establish the components of each CDS section (e.g. General Clinical, Cognitive/Behavioral, Postmortem Brain Neuropathological Findings). The PD-DOC CDS was established and designed to optimize data analyses and data mining for large numbers of subjects participating in a variety of research studies. In most cases corresponding DNA samples are available form the NINDS Human Genetic Repository (at Coriell). Much of the website is publicly available for viewing. To request access to sections of the website dealing with downloading or requesting data, requesting a consultation, or submitting data or other information you will need to register. Before registering, you should read the PD-DOC Policies. Note that PD-DOC data can be used for research purposes only. Once your registration is successfully completed you will be automatically logged into the website. | data, parkinson's disease, translational research, clinical, gds-15, cowat, dna, hoehn and yahr, idiopathic pd, lnst, merq, mmse, npi-q, parkinsonism, se/adl, updrs |
is related to: NINDS Repository has parent organization: University of Rochester; New York; USA |
NINDS U01NS050095 | THIS RESOURCE IS NO LONGER IN SERVICE | nif-0000-10109 | SCR_001596 | The Parkinson's Disease Data and Organizing Center (PD-DOC), Parkinson's Disease Data and Organizing Center, The Parkinson's Disease Data and Organizing Center | 2026-09-12 12:55:28 | 0 | ||||||
|
Epidemiology of Diabetes Interventions and Complications Resource Report Resource Website 1+ mentions |
Epidemiology of Diabetes Interventions and Complications (RRID:SCR_001468) | EDIC | bibliography, clinical trial, data or information resource, database, resource | Publications from a multi-center, longitudinal, observational study examining the risk factors associated with the long-term complications of type 1 diabetes. The study began in 1994 and follows the 1441 participants previously enrolled in the Diabetes Control and Complications Trial (DCCT), http://diabetes.niddk.nih.gov/dm/pubs/control/index.aspx. The primary aim of EDIC is to examine the long-term effects of conventional vs. intensive diabetes treatment received during the DCCT on the subsequent development and progression of microvascular, neuropathic and cardiovascular complications. This involves studying the influence of genetic factors and other factors such as HbA1c, blood pressure, lipid levels, and treatment modalities on the development and progression of these complications. Annual or biennial measurements (using DCCT methods, standardized protocols and central laboratories) of vascular events, albumin excretion, GFR, ECG, ankle-brachial BP index, serum lipids and HbA1c allows the following analyses: 1) continuation of intention-to-treat analyses to determine long-term effects of prior separation of glycemic levels; 2) risk factors for macrovascular outcomes; 3) correlation of progression of micro- and macrovascular outcomes. The current updated version of the EDIC Protocol is available for download. EDIC is made up of 28 clinical centers, one data coordinating center and one clinical coordinating center. | longitudinal, observational, nephropathy, macrovascular, complication, risk factor, clinical, genetic factor, hba1c, blood pressure, lipid level, treatment modality, complication |
is listed by: ClinicalTrials.gov is listed by: NIDDK Information Network (dkNET) is listed by: NIDDK Central Repository is related to: Diabetes Control and Complications Trial is related to: Diabetes Control and Complications Trial has parent organization: George Washington University; Washington D.C.; USA |
Type 1 diabetes, Diabetes | NIDDK 4U01DK094157 | Free, Freely Available | nlx_152698 | SCR_001468 | 2026-09-12 12:55:26 | 1 | ||||||
|
Adult to Adult Living Donor Liver Transplantation Cohort Study Resource Report Resource Website |
Adult to Adult Living Donor Liver Transplantation Cohort Study (RRID:SCR_001494) | A2ALL | data or information resource, disease-related portal, portal, research forum portal, resource, topical portal | Study consisting of nine liver transplant centers with expertise in adult living-donor liver transplantation (LDLT) and a central data coordinating center to provide valuable information on the outcomes of adult to adult living donor liver transplantation (AALDLT) to aid decisions made by physicians, patients, and potential donors. The study will establish and maintain the infrastructure required to accrue and follow sufficient numbers of patients being considered for and undergoing AALDLT to provide generalizable data from adequately powered studies. The major aims of A2ALL are as follows: * Quantify the impact of choosing LDLT on the candidate for transplantation * Characterize the difference between LDLT and deceased donor liver transplant (DDLT) in terms of post-transplant outcomes, including patient and graft survival, surgical morbidity, and resource utilization on the recipient of a transplant * Determine the short- and long-term health and quality of life (QOL) impact of donation, including (a) morbidity after liver donation and (b) long-term health-related QOL of donors. * Standardize and assess the role of informed consent in affecting the decision to donate and satisfaction after living liver donation * Other aims include comparison of the severity of recurrence of hepatocellular carcinoma for DDLT versus LDLT, the systematic characterization of liver regeneration and function in donors and recipients, the evaluation of the differences in the immune response to LDLT versus DDLT, and the establishment of a robust data and sample repository on liver transplantation that may be used to study clinical and biological questions as new technologies and resources become available. Patients enrolled in the study will be followed and managed in a standardized fashion. | transplant, liver, adult human, risk factor, surgery, outcome, quality of life, clinical |
is listed by: NIDDK Information Network (dkNET) has parent organization: University of Michigan; Ann Arbor; USA |
Liver transplant, Liver disease | NIDDK 1U01DK62498 | PMID:18976306 PMID:18756453 PMID:16135918 |
Free, Freely available | nlx_152749 | http://www.nih-a2all.org/ | SCR_001494 | A2ALL: The Adult to Adult Living Donor Liver Transplantation Cohort Study | 2026-09-12 12:55:26 | 0 | |||
|
Behavior Enhances Drug Reduction of Incontinence Resource Report Resource Website |
Behavior Enhances Drug Reduction of Incontinence (RRID:SCR_001495) | BE-DRI | bibliography, clinical trial, data or information resource, resource | Multi-center randomized clinical trial to determine if the addition of behavioral treatment to drug therapy for the treatment of urge incontinence will make it possible to discontinue the drug and still maintain a reduced number of accidents. The most popular treatments for urge incontinence are drug therapy and behavior therapy, each with its own limitations. In this clinical study, the Urinary Incontinence Treatment Network (UITN) aims to determine differences with the addition of behavioral treatment to drug therapy alone. | drug therapy, behavioral therapy, female, urinary incontinence, overactive bladder, combined modality therapy, quality of life, pelvic floor muscle exercise, tolterodine, clinical |
is listed by: ClinicalTrials.gov is listed by: NIDDK Information Network (dkNET) has parent organization: Urinary Incontinence Treatment Network |
Urge incontinence, Urinary Incontinence | NIDDK U01DK58225; NIDDK U01DK58234; NIDDK U01DK58229; NIDDK U01DK58231; NIDDK U01DK60397; NIDDK U01DK60401; NIDDK U01DK60395; NIDDK U01DK60393; NIDDK U01DK60380; NIDDK U01DK60379 |
PMID:16919506 | Free, Freely available | nlx_152752 | http://www.uitn.net/bedri.asp | SCR_001495 | 2026-09-12 12:55:26 | 0 | ||||
|
Standardization of C-peptide measurements Resource Report Resource Website |
Standardization of C-peptide measurements (RRID:SCR_001499) | Standardization of c-peptide | data or information resource, narrative resource, resource, standard specification | Standardization of c-peptide by calibrating C-peptide measurement to a reference method can increase comparability between laboratories. The C-peptide standardization program is supported to establish reliability in results and facilitate the conduct of international clinical trials. For c-peptide, purified or processed material shows significant matrix effects and cannot be used for calibration. The C-peptide program has evaluated the use of single donor and pooled specimens for use by manufacturers in the calibration of these assays and determined that this strategy will reduce C-peptide variability among different assay methods. The standardization process through manufacturer re-calibration is ongoing. | c-peptide, insulin secretion, clinical, calibration |
is listed by: NIDDK Information Network (dkNET) has parent organization: University of Missouri School of Medicine; Missouri; USA |
Diabetes | NIDDK 200200409985 | PMID:18420730 | Free, Freely available | nlx_152766 | SCR_001499 | C-peptide Standardization | 2026-09-12 12:55:26 | 0 | ||||
|
Diabetic Retinopathy Clinical Research Network Resource Report Resource Website 1+ mentions |
Diabetic Retinopathy Clinical Research Network (RRID:SCR_001514) | DRCR.net, DRCRnet | bibliography, clinical trial, data or information resource, data set, disease-related portal, portal, research forum portal, slide, topical portal | A collaborative network to facilitate multicenter clinical research of diabetic retinopathy, diabetic macular edema and associated conditions. It supports the identification, design, and implementation of multicenter clinical research initiatives focused on diabetes-induced retinal disorders. Principal emphasis is placed on clinical trials, but epidemiologic outcomes and other research may be supported as well. It currently includes over 109 participating sites (offices) with over 320 physicians throughout the United States. Closed and active studies are listed along with the associated protocols, public datasets, and publications. | eye, retina, clinical, clinical trial, epidemiology, outcome, ophthalmic, ophthalmology, experimental protocol |
is listed by: NIDDK Information Network (dkNET) has parent organization: Jaeb Center for Health Research |
Diabetic retinopathy, Diabetic macular edema, Diabetes, Retinopathy, Macular edema, Diabetes-induced retinal disorder | NEI EY14231; NEI EY018817 |
Public, Registration required, To download data sets | nlx_152816 | SCR_001514 | Diabetic Retinopathy Clinical Research Network (DRCR.net), DRCR Network | 2026-09-12 12:55:26 | 1 | |||||
|
Longitudinal Assessment of Bariatric Surgery Resource Report Resource Website 1+ mentions |
Longitudinal Assessment of Bariatric Surgery (RRID:SCR_001536) | LABS | data or information resource, disease-related portal, narrative resource, portal, research forum portal, resource, topical portal | Consortium comprised of six clinical centers and a data coordinating center to facilitate coordinated clinical, epidemiological, and behavioral research in the field of bariatric surgery, through the cooperative development of common clinical protocols and a bariatric surgery database that will collect information from participating clinical centers. LABS will help pool the necessary clinical expertise and administrative resources to facilitate the conduct of multiple clinical studies in a timely, efficient manner. Also, the use of standardized definitions, clinical protocols, and data-collection instruments will enhance the investigator's ability to provide meaningful evidence-based recommendations for patient evaluation, selection, and follow-up care. The consortium was funded in September 2003. The investigators have collaboratively developed a core database and clinical protocols, and subject enrollment began in early 2005. A repository of data and biological specimens for future research also will be collected by the centers participating in LABS. These will provide valuable resources for future study of obesity and its complications. | clinical, epidemiology, behavior, longitudinal, risk, benefit, surgical procedure, clinical outcome, database, clinical trial, experimental protocol, biomaterial supply resource |
is listed by: NIDDK Information Network (dkNET) is listed by: NIDDK Research Resources has parent organization: University of Pittsburgh; Pennsylvania; USA |
Bariatric surgery, Obesity | NIDDK 5U01DK066557 | nlx_152842 | SCR_001536 | Longitudinal Assessment of Bariatric Surgery Consortium, LABS consortium, Longitudinal Assessment of Bariatric Surgery (LABS) Consortium | 2026-09-12 12:55:27 | 1 | ||||||
|
Sanford-Burnham Neuroscience and Aging Research Center Resource Report Resource Website 1+ mentions |
Sanford-Burnham Neuroscience and Aging Research Center (RRID:SCR_001688) | NARC | data or information resource, portal, topical portal | Center that translates basic science discoveries into new treatments to extend lifespan and to combat degenerative disorders associated with aging or development. Their researchers are discovering the etiological pathways as well as small-molecule and stem cell-based treatments to address the clinical unmet need of these patients. The Center uses a team based approach to apply their expertise in stem cells to develop therapies for new treatments for stroke and Parkinson's disease. They are also performing high-throughput screens to identify new molecules to protect the synapses of nervesthe connections between nerves that mediate movement, memory and cognition for Alzheimer's, Parkinson's and autism. By studying the links between Down syndrome and Alzheimer's disease, they are exploring new treatments to improve cognition in both disorders. Their collaborations with clinical partners enable them to test new discoveries in human trials, with a goal to improve the lives of patients and families affected by neurodegenerative disease and aging disorders. | neuron, cell, clinical, pathway, small molecule, stem cell, treatment, drug, synapse, nerve | has parent organization: Sanford Burnham Prebys Medical Discovery Institute | Aging, Alzheimer's disease, Parkinson's disease, Autism, Neurodegenerative disease, Aging disorder, Down syndrome, Stroke | Free, Freely Available | nif-0000-10181 | http://www.sanfordburnham.org/research/neuroscience/Pages/Home.aspx | SCR_001688 | NASCR, Neuroscience and Aging Research Center, Sanford-Burnham Del E. Webb Neuroscience Aging and Stem Cell Research Center, Del E. Webb Neuroscience Aging and Stem Cell Research Center, Sanford-Burnham NASCR, Burnham Institute NASCR | 2026-09-12 12:55:29 | 4 | |||||
|
CAMRD Resource Report Resource Website |
CAMRD (RRID:SCR_001713) | CAMRD | access service resource, service resource | Research facility of the Department of Radiology at the Duke University Medical Center (DUMC) providing access to a whole-body, commercially manufactured 3 Tesla (Trio, Siemens Medical Systems) MR Imaging and Spectroscopy System with full research capability. The Center is fully equipped to perform clinical and research MR imaging or spectroscopy studies on humans or large animals. A full range of monitoring, anesthesia, RF coil development, computer and instrumental control facilities as well as MR research technologists and physics/chemistry consultation are available to Department of Radiology researchers and their collaborators. | anesthesia, animal, chemistry, human, imaging, magnetic resonance, monitoring, mri, physics, radiology, research, rf coil, spectroscopy, technology, tesla, mr spectroscopy, clinical, research |
is related to: Beta Cell Biology Consortium has parent organization: Duke University; North Carolina; USA |
Free, Freely Available | nif-0000-10211 | http://camrd4.mc.duke.edu/ | SCR_001713 | Duke Center for Advanced Magnetic Resonance Development, Duke University Medical Center, DUMC CAMRD, DUMC Center for Advanced Magnetic Resonance Development, Center for Advanced Magnetic Resonance Development, Department of Radiology: Center for Advanced Magnetic Resonance Development | 2026-09-12 12:55:29 | 0 | ||||||
|
Journal of Cerebral Blood Flow and Metabolism Resource Report Resource Website 10+ mentions |
Journal of Cerebral Blood Flow and Metabolism (RRID:SCR_001769) | JCBFM | journal article | The Journal of Cerebral Blood Flow & Metabolism stands at the interface between basic and clinical neurovascular research, and features timely and relevant research highlighting experimental, theoretical, and clinical aspects of brain circulation, metabolism and imaging. The journal is relevant to any physician or scientist with an interest in brain function, cerebrovascular disease, cerebral vascular regulation and brain metabolism, including neurologists, neurochemists, physiologists, pharmacologists, anesthesiologists, neuroradiologists, neurosurgeons, neuropathologists and neuroscientists. On this website, you will find the full text of articles published online weekly, in advance of print, the current issue and an archive of previous issues. You can also find general information about the journal, and more detailed information for readers, authors, referees, librarians, advertisers, and journalists. Most articles are published online before they appear in print. New papers are uploaded weekly to the Advance online publication (AOP) page. The online publication date is specified for each paper; these versions are identical to the printed version in every respect and may be cited using the digital object identifier (DOI). | function, anesthesiologist, article, blood, brain, cerebral, cerebrovascular, circulation, clinical, disease, imaging, metabolism, neurochemist, neurologist, neuropathologist, neuroradiologist, neuroscientist, neurosurgeon, neurovascular, pharmacologist, physiologist, regulation, vascular |
is related to: ISCBFM - International Society for Cerebral Blood Flow and Metabolism has parent organization: Nature Publishing Group |
Free, Freely available | nif-0000-10274 | SCR_001769 | 2026-09-12 12:55:31 | 36 | ||||||||
|
OBART Resource Report Resource Website 1+ mentions |
OBART (RRID:SCR_001903) | OBART | atlas, data or information resource, software resource, web application | Tool that provides an interactive method to examine quantitative relationships between brain regions defined by different digital atlases or parcellation methods. Its current focus is for human brain imaging, though the techniques generalize to other domains. The method offers a quantitative answer to the nomenclature problem in neuroscience by comparing brain parts on the basis of their geometrical definitions rather than on the basis of name alone. Thus far these tools have been used to quantitatively compare eight distinct parcellations of the International Consortium for Brain Mapping (ICBM) single-subject template brain, each created using existing atlasing methods. This resources provides measures of global and regional similarity, and offers visualization techniques that allow users to quickly identify the correspondences (or lack of correspondences) between regions defined by different atlases. | atlas, brain, clinical, mapping, meta-analysis, neuroscience, visualization, label |
is listed by: NeuroImaging Tools and Resources Collaboratory (NITRC) has parent organization: Brain Architecture Project has parent organization: Boston University; Massachusetts; USA |
NIMH 5R01MH084802 | PMID:19787067 | THIS RESOURCE IS NO LONGER IN SERVICE | nif-0000-10473 | http://www.nitrc.org/projects/obart | http://obart.brainarchitecture.org | SCR_001903 | The Online Brain Atlas Reconciliation Tool, Online Brain Atlas Reconciliation Tool | 2026-09-12 12:55:33 | 2 | |||
|
National Institutes of Health Stroke Scale Resource Report Resource Website 100+ mentions |
National Institutes of Health Stroke Scale (RRID:SCR_001804) | data or information resource, portal, topical portal | The National Institutes of Health Stroke Scale (NIHSS) is a systematic assessment tool that provides a quantitative measure of stroke-related neurological deficit. The NIHSS was originally designed as a research tool to measure baseline data on patients in acute stroke clinical trials. Now, the scale is also widely used as a clinical assessment tool to evaluate acuity of stroke patients, determine appropriate treatment, and predict patient outcome. The NIHSS can be used as a clinical stroke assessment tool to evaluate and document neurological status in acute stroke patients. The stroke scale is valid for predicting lesion size and can serve as a measure of stroke severity. The NIHSS has been shown to be a predictor of both short and long term outcome of stroke patients. Additionally, the stroke scale serves as a data collection tool for planning patient care and provides a common language for information exchanges among healthcare providers. Performing the scale takes between 5-8 minutes. Emergency physicians and nurses, neurologists, neuroscience nurses and other stroke team members are typical examples of who should be certified to perform the NIHSS. The NINDS/NIH training and testing DVD can be obtained from the National Institute of Neurological Disorders and Stroke. Sponsors: NIHSS is supported by the National Institute of Neurological Disorders and Stroke (NINDS). | acute, care, clinical, deficit, healthcare, lesion, neurological, neurologist, neuroscience, nurse, patient, physician, stroke, treatment, language | Free, Freely available | nif-0000-10368 | http://www.stroke.org/site/PageNavigator/NIHSS | SCR_001804 | NIHSS | 2026-09-12 12:55:31 | 356 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
